The Biosimilars Council, a division of the Association for Accessible Medicines, works to increase patient access to lifesaving, affordable biosimilar medicines. Leveraging our deep relationships on Capitol Hill, in federal agencies like FDA and CMS, and in the states, we strive to create a positive regulatory, reimbursement, political and policy environment to assure biosimilars thrive, providing billions in savings to patients and the health care system. Our members include biosimilar manufacturers and stakeholders working to promote biosimilar products in the U.S. market.
Company Details
- Address
- 601 New Jersey Ave, Nw,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- biosimilarscouncil.org
- HQ
- Washington, District of Columbia
- Competitors
- IQVIA Institute for Human Data Science, Association for Accessible Medicines, Biosimilar Development, IGBA - International Generic and Biosimilar medicines Association, Festival of Biologics, Amneal Pharmaceuticals, Biosimilars Forum, Medicines for Europe, Generics and Biosimilars Initiative (GaBI), The Center for Biosimilars.
Biosimilars Council Questions
Biosimilars Council's website is biosimilarscouncil.org
Biosimilars Council's LinkedIn profile is https://www.linkedin.com/company/biosimscouncil
Biosimilars Council's industry is
Pharmaceutical Manufacturing
Biosimilars Council's top competitors are
Iqvia Institute For Human Data Science,
Association For Accessible Medicines,
Biosimilar Development,
Igba - International Generic And Biosimilar Medicines Association,
Festival Of Biologics,
Amneal Pharmaceuticals,
Biosimilars Forum,
Medicines For Europe,
Generics And Biosimilars Initiative (Gabi),
The Center For Biosimilars.
Biosimilars Council's categories are Pharmaceutical Manufacturing
